- Home
- JMIA vs MDXG Comparison
JMIA vs MDXG Comparison
Compare JMIA & MDXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JMIA
- MDXG
- Stock Information
- Founded
- JMIA 2012
- MDXG 2006
- Country
- JMIA Germany
- MDXG United States
- Employees
- JMIA N/A
- MDXG N/A
- Industry
- JMIA Catalog/Specialty Distribution
- MDXG Biotechnology: Pharmaceutical Preparations
- Sector
- JMIA Consumer Discretionary
- MDXG Health Care
- Exchange
- JMIA Nasdaq
- MDXG Nasdaq
- Market Cap
- JMIA 1.2B
- MDXG 1.0B
- IPO Year
- JMIA 2019
- MDXG N/A
- Fundamental
- Price
- JMIA $10.89
- MDXG $7.74
- Analyst Decision
- JMIA Buy
- MDXG Buy
- Analyst Count
- JMIA 1
- MDXG 1
- Target Price
- JMIA $15.00
- MDXG $12.00
- AVG Volume (30 Days)
- JMIA 2.4M
- MDXG 951.5K
- Earning Date
- JMIA 01-01-0001
- MDXG 10-29-2025
- Dividend Yield
- JMIA N/A
- MDXG N/A
- EPS Growth
- JMIA N/A
- MDXG N/A
- EPS
- JMIA N/A
- MDXG 0.27
- Revenue
- JMIA $164,022,000.00
- MDXG $393,442,000.00
- Revenue This Year
- JMIA $21.84
- MDXG $12.68
- Revenue Next Year
- JMIA $12.09
- MDXG $8.18
- P/E Ratio
- JMIA N/A
- MDXG $28.47
- Revenue Growth
- JMIA N/A
- MDXG 14.77
- 52 Week Low
- JMIA $1.60
- MDXG $5.79
- 52 Week High
- JMIA $13.14
- MDXG $10.14
- Technical
- Relative Strength Index (RSI)
- JMIA 46.42
- MDXG 68.09
- Support Level
- JMIA $9.91
- MDXG $6.68
- Resistance Level
- JMIA $12.16
- MDXG $7.89
- Average True Range (ATR)
- JMIA 0.58
- MDXG 0.31
- MACD
- JMIA -0.13
- MDXG 0.12
- Stochastic Oscillator
- JMIA 34.74
- MDXG 84.01
About JMIA Jumia Technologies AG each representing two
Jumia Technologies AG is the pan-African e-commerce platform. The company's platform consists of a marketplace, which connects sellers with consumers. Its logistics service enables the shipment and delivery of packages from sellers to consumers, and the company's payment service facilitates transactions among participants active on its platform in selected markets. Jumia generates revenue from Sales of goods, Commissions, Fulfillment, Value-added services, and Marketing & Advertising. Its geographical segments are West Africa, North Africa, East & South Africa, Europe, and United Arab Emirates. The firm generates majority of its revenue from the West Africa segment.
About MDXG MiMedx Group Inc
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.